Clinical Trials in Austin

Showing 8321-8340 of 15,205 trials

BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence

NCT03861936

Based on the results of the Phase 2 Study 191622-130 \[NCT02010775\], the current Phase 2b study is designed to further evaluate the safety and efficacy of BOTOX® for the treatment of Masseter Muscle Prominence (MMP) in adults.

Masseter Muscle Prominence

Allergan150 participantsStarted May 2019

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +11 more locations

COMPLETED< 1 mile

Redesigning the Care Journey of Patients With Single-ventricle Congenital Heart Disease

NCT04613934

In this three-party collaboration, which includes The Texas Center for Pediatric and Congenital Heart Disease, the Value Institute for Health and Care, and the Design Institute for Health, all from University of Texas (UT) Dell Medical School, the investigators will explore how patient insights, data, storytelling, ideation, and prototyping can be employed to design a care delivery solution that enables patient outcome improvement. The goal of this project is to understand the life journey of patients with single-ventricle congenital heart disease and understand areas of that journey that can be improved. As such, the project intentionally does not start with a hypothesis, but instead seeks to gain insight of single-ventricle patients' care journey and based on that understanding identify opportunities for improvement.

Single-ventricleCongenital Heart Disease

University of Texas at Austin142 participantsStarted Feb 2020

Austin, Texas, United States

BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence

Redesigning the Care Journey of Patients With Single-ventricle Congenital Heart Disease

Find Trials by Condition in Austin

Telehealth Depression Treatments for Older Adults

Effect of Food on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Adults

Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System™ in Femoropoliteal Arteries

Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients

Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)

Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis

Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease

Post Approval Study of the remedē System

Age of Blood in Children in Pediatric Intensive Care Units

Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.

Global Anticoagulant Registry in the Field

A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Corneal Collagen Cross-Linking for Ectasia (CXL)

Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Risk Factors

Efficacy and Safety Study of Polidocanol Injectable Foam for the Treatment of Saphenofemoral Junction (SFJ) Incompetence

Heart Sounds Registry

Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event